www.independent.co.uk
3 weeks agoPrivacy professionals
Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after COVID delays, AP finds
FDA inspections of pharmaceutical plants have not recovered from pandemic delays, risking drug safety for millions of Americans. [ more ]